Current CDC surveillance shows no active Level 4 Travel Health Notices, with the highest alerts limited to Level 3 for Ebola Bundibugyo virus disease in the Democratic Republic of the Congo as of May 18, 2026, and multiple Level 2 notices for polio across roughly 30 countries, chikungunya, meningococcal disease, and yellow fever. Level 4 status requires an extreme health risk where no precautions suffice, a threshold not approached by these outbreaks given available vaccines, containment measures, and transmission patterns. Trader consensus favoring “No” at 78% reflects the absence of conditions matching historical precedents for such notices, such as uncontrolled high-mortality outbreaks, alongside ongoing monitoring that has not triggered escalation in recent months. New data from CDC updates or emerging variants could shift this assessment before year-end.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日はい
$71,630 Vol.
$71,630 Vol.
はい
$71,630 Vol.
$71,630 Vol.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
マーケット開始日: Jan 19, 2026, 3:15 PM ET
Resolver
0x65070BE91...A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...Current CDC surveillance shows no active Level 4 Travel Health Notices, with the highest alerts limited to Level 3 for Ebola Bundibugyo virus disease in the Democratic Republic of the Congo as of May 18, 2026, and multiple Level 2 notices for polio across roughly 30 countries, chikungunya, meningococcal disease, and yellow fever. Level 4 status requires an extreme health risk where no precautions suffice, a threshold not approached by these outbreaks given available vaccines, containment measures, and transmission patterns. Trader consensus favoring “No” at 78% reflects the absence of conditions matching historical precedents for such notices, such as uncontrolled high-mortality outbreaks, alongside ongoing monitoring that has not triggered escalation in recent months. New data from CDC updates or emerging variants could shift this assessment before year-end.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日
外部リンクに注意してください。
外部リンクに注意してください。
よくある質問